Ahava 2021 |
Ineligible index test (lab‐based antigen assay) |
Aoki 2020 |
Ineligible index test (lab‐based antigen assay) |
Bello‐Chavolla 2021 |
Ineligible index test (multiple assays used) |
Chen 2021 |
Ineligible study design (proof of concept) |
Corman 2020 |
Ineligible study design (analytical accuracy) |
Cubas‐Atienzar 2021 |
Ineligible study design (analytical accuracy) |
Dalal 2021 |
Ineligible study design |
Diao 2020 |
Exclude on index test ‐ not commercially available |
Dohla 2020 |
Ineligible index test |
Downs 2021 |
Ineligible study design (multiple samples per participant; only gives overall positivity rates) |
Eshghifar 2021 |
Inadequate sample size (also analytical accuracy) |
Frnda 2021 |
Accuracy data cannot be extracted |
Gili 2021 |
Ineligible index test (lab‐based antigen assay) |
Haage 2021a |
Ineligible population |
Haage 2021b |
Ineligible study design |
Herrera 2020 |
Ineligible reference standard |
Hingrat 2020 |
Ineligible index test (lab‐based antigen assay) |
Hirotsu 2020 |
Ineligible index test |
Hirotsu 2021 |
Ineligible index test (lab‐based antigen assay) |
Hledik 2020 |
Accuracy data cannot be extracted |
Hoehl 2020 |
Ineligible study design |
Kannian 2021 |
Ineligible population (cases PCR positive on NP and saliva; controls PCR negative on saliva but half positive on NP swabs) |
Kashiwagi 2020 |
Inadequate sample size |
Kobayashi 2021 |
Ineligible index test (lab‐based antigen assay) |
Koskinen 2021 |
Ineligible index test (lab‐based antigen assay) |
Kotsiou 2021 |
Accuracy data cannot be extracted (PPV only) |
Kurstjens 2020 |
Ineligible index test |
Kyosei 2020 |
Ineligible study design |
Lefever 2021 |
Ineligible index test (laboratory‐based assay) |
Le Hingrat 2020 |
Ineligible index test |
Li 2021 |
Inelligible index test (in‐house microfluidic assay) |
Liu 2021 |
Ineligible index test (in‐house CLIA) |
Mahari 2020 |
Ineligible study design |
Mak 2020a |
Ineligible study design (deliberate sampling by Ct values; analytical accuracy) |
Mak 2020b |
Ineligible study design (deliberate sampling by Ct values; analytical accuracy) |
Marzinotto 2020 |
Accuracy data cannot be extracted |
Mboumba 2021 |
Ineligible study design (analytical accuracy) |
McAulay 2020 |
Ineligible index test (uses serum samples) |
McDonald 2020 |
Ineligible reference standard |
Menchinelli 2021 |
Ineligible index test (lab‐based antigen assay) |
Mohamed 2021 |
Ineligible study design |
Moreno 2021 |
Accuracy data cannot be extracted |
Nachtigall 2020 |
Ineligible index test |
Ogawa 2020 |
Inadequate sample size |
Pavelka 2020 |
Ineligible study design |
Pekosz 2021 |
Ineligible reference standard (also reports subgroup of Young 2020 ) |
Pellanda 2020 |
Ineligible index test |
Peng 2020 |
Ineligible study design |
Perchetti 2020 |
Ineligible study design |
Pollock 2020a |
Ineligible index test |
Rastawicki 2021 |
Ineligible study design (serial testing in hospitalised patients) |
Regev‐Yochay 2021 |
Ineligible index test (multiple assays used) |
Ren 2021 |
Ineligible index test (lab‐based antigen assay) |
Rodriguez‐Manzano 2020 |
Ineligible index test |
Rusanen 2020 |
Ineligible index test (lab‐based antigen assay) |
Scheiblauer 2021 |
Ineligible study design (analytical accuracy only) |
Seitz 2021 |
Accuracy data cannot be extracted (confused reporting) |
Seo 2020 |
Accuracy data cannot be extracted |
Singh 2020a |
Ineligible index test |
Singh 2020b |
Ineligible index test |
Wang 2020 |
Ineligible index test (amplification‐free nucleic acid immunoassay) |
Wu 2020 |
Ineligible index test |
Yamamoto 2021 |
Ineligible population (all COVID‐19 inpatients; specificity in previously positive patients) |
Yamayoshi 2020 |
Ineligible study design (analytical accuracy only) |
Yokota 2021 |
Ineligible index test (lab‐based antigen assay) |
Yu 2020 |
Ineligible index test |
Zamecnik 2020 |
Ineligible index test |
Zeng 2020 |
Ineligible study design |
Zhang 2020 |
Ineligible index test |